Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Plastin-1 (PLS1), also called fimbrin or I-plastin, is an intestine-specific actin-bundling and cross-linking protein predominantly expressed in the microvilli of intestinal and kidney epithelial cells and in hair cell stereocilia. It belongs to a family of cytoskeletal proteins critical for assembling and stabilizing tightly bundled actin filaments, which are essential for the structure and resilience of membrane protrusions such as microvilli and stereocilia. Loss of PLS1 affects intestinal brush border morphology, leading to increased epithelial cell fragility and susceptibility to inflammation, and mutations in the gene are associated with hereditary hearing loss. There are no known drugs directly targeting PLS1, and it is not considered a major therapeutic target at this time.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Plastin-1 (PLS1).